NCI Clinical Research Foundation, Inc. is a non-profit organization based in Mount Arlington, NJ, dedicated to advancing the diagnosis and treatment of neurocognitive and neuropsychiatric disorders. Their team of expert neuroscientists specializes in various fields, including cognitive neuroscience, neuroimaging, neuropharmacology, and neuromodulation, with a focus on neurodevelopmental and neurodegenerative diseases, traumatic brain injury, and behavioral sciences.
The foundation conducts cutting-edge research in areas such as identifying biomarkers for Alzheimer's disease, investigating connectivity changes in mild cognitive impairment, studying cortical network abnormalities in autism, and developing innovative treatments for cognitive and neuropsychiatric disorders. Led by Dr. Gerald Tramontano, a renowned clinical neuropsychologist and researcher, the foundation has completed numerous clinical trials and published neuroscience-related articles in medical and forensic journals. Their mission is to discover new and improved methods for diagnosing and treating neurocognitive and neuropsychiatric disorders.
Generated from the website